Patients with facial spasm are usually treated with medication after the onset of the disease, and in severe cases, surgery may be an option, so early diagnosis and treatment are recommended. Facial myospasm is a multifaceted and common neurological disorder characterized by twitching of unilateral facial muscles. Although facial spasm is considered a benign disorder, the resulting social embarrassment is particularly painful for patients, and the immense psychological stress often causes the patient’s quality of life to plummet. To be on the safe side, many patients opt for medication. Most doctors recommend that patients take carbamazepine, an epilepsy drug that works better for patients with early onset facial spasms. However, the side effects of carbamazepine are large, and patients who do not tolerate side effects should not take this type of medication. Some patients also take methylcobalamin and vitamin B1, which, again, can provide relief for patients with mild facial spasms, but prolonged use of anti-neuritis drugs can cause the patient’s body to develop resistance and make the treatment less and less effective. When medication fails to relieve a patient’s condition, medication should be abandoned and treatment should be turned to surgery. According to the World Health Organization, more than 90% of patients with facial muscle spasms are the result of compression of the facial nerve by the responsible blood vessels. Microvascular decompression is an excellent minimally invasive treatment for this pathogenesis, aiming to eliminate the compression of the facial nerve root by the abnormal/dilated blood vessels. Since the introduction of microvascular decompression, the Civil Aviation General Hospital has successfully relieved more than 30,000 patients from facial spasm, with a success rate of more than 98%, which is the first-class level in China and the international advanced level. The onset of facial muscle spasm should not be underestimated, must choose the regular hospital for treatment, not to delay, if delayed treatment is prone to more disease occurrence.